Results 151 to 160 of about 3,543 (186)

Evidence of a putative new species Haemagogus 'Trinidad sp. A' from the Caribbean sharing mitogenome lineages with species endemic to the Amazon. [PDF]

open access: yesSci Rep
Ali RLMN   +8 more
europepmc   +1 more source

A cluster of Mayaro virus infections in a film team returning from Suriname, February 2024. [PDF]

open access: yesEuro Surveill
Orth HM   +10 more
europepmc   +1 more source

Exposure to non-endemic arboviruses (alphaviruses) in Costa Rica assessed from human samples collected in areas with contrasting levels of dengue endemicity. [PDF]

open access: yesFront Public Health
Valles-Morera A   +9 more
europepmc   +1 more source

Rapid differentiation of VLA1553 and wild-type ECSA chikungunya strains in the context of an IXCHIQ vaccination campaign. [PDF]

open access: yesEmerg Microbes Infect
Pezzi L   +14 more
europepmc   +1 more source

The CRISPR-Cas toolkit for mosquito-borne virus surveillance: detection, tracing, and discovery. [PDF]

open access: yesFront Cell Infect Microbiol
Wu Y   +10 more
europepmc   +1 more source

Mayaro virus fever: a necessary alert

open access: yesRevista Habanera de Ciencias Médicas, 2016
openaire   +1 more source

Mayaro Virus Pathogenesis and Transmission Mechanisms [PDF]

open access: yesPathogens, 2020
Mayaro virus (MAYV), isolated for the first time in Trinidad and Tobago, has captured the attention of public health authorities worldwide following recent outbreaks in the Americas. It has a propensity to be exported outside its original geographical range, because of the vast distribution of its vectors.
Rodolphe Hamel   +2 more
exaly   +6 more sources

Repurposing Drugs for Mayaro Virus: Identification of EIDD-1931, Favipiravir and Suramin as Mayaro Virus Inhibitors [PDF]

open access: yesMicroorganisms, 2021
Despite the emerging threat of the Mayaro virus (MAYV) in Central and South-America, there are no licensed antivirals or vaccines available for this neglected mosquito-borne virus. Here, we optimized a robust antiviral assay based on the inhibition of the cytopathogenic effect that could be used for high-throughput screening to identify MAYV inhibitors.
Lana Langendries   +2 more
exaly   +4 more sources

Home - About - Disclaimer - Privacy